Page URL:

Genomics traces COVID-19 transmission chains in the UK

18 January 2021
Appeared in BioNews 1079

Genomic epidemiological analysis of the initial UK COVID-19 outbreak has allowed a team of researchers to accurately characterise the early chains of transmission throughout the country. 

A collaboration between the Universities of Oxford and Edinburgh has produced the most extensive genomic analysis of any known epidemic by studying over 50,000 SARS-CoV-2 genomes. This genomic data, the majority of which was sourced from the COVID-19 Genomics UK consortium, was used in conjunction with travel data to retrospectively trace and map individual virus transmission lineages from the first wave.

'By reconstructing where and when COVID-19 was introduced to the UK we can see that earlier travel and quarantine interventions could have helped to reduce the acceleration and intensity of the UK's first wave of cases' said lead author Professor Oliver Pybus, from the University of Oxford's Department of Zoology.

The full study, published in Science, revealed that the virus was imported into the UK over 1000 times prior to the March 2020 lockdown. Results also showed that the origin and rate of introduction evolved rapidly over time. During the early months of last year, the highest sources of importation were from Spain (33 percent), France (29 percent), and Italy (12 percent). Only 0.4 percent of such cases were imported directly from China. 

It appears that more than 1000 identifiable transmission lineages were already established and co-circulating in the UK prior to the first lockdown, including the eight most wide-spread and persistent lineages. While the introduction of the national lockdown coincided with a reduction in new lineage importation, extinction of lineages was only seen in areas of low prevalence. Earlier lineages, which were larger and more widely dispersed, survived national restrictions and continued to persist once measures were eased.

The research team, which contributed to the identification of the rapidly spreading 'new variant' B.1.1.7, is currently investigating the extent to which earlier persistent lineages are contributing to the more recent waves of COVID-19. This genomic surveillance of the ongoing epidemic provides crucial information to guide future public health actions. 

'This kind of continuous, nationally coordinated genomic sequencing not only allows the high-resolution analysis we present, but also helps other countries to place their genomic data into context and assists the global pandemic response,' said co-author Verity Hill from the University of Edinburgh.

COVID-19 transmission chains in the UK accurately traced using genomic epidemiology
University of Oxford |  12 January 2021
Establishment and lineage dynamics of the SARS-CoV-2 epidemic in the UK
Science |  8 January 2021
Mapping the introduction of the COVID-19 epidemic in the United Kingdom using genomic analysis
EurekAlert |  8 January 2021
SARS-CoV-2 genomic analysis traces UK transmission lineages
Genetic Engineering and Biotechnology News |  11 January 2021
18 October 2021 - by Hannah Flynn 
Genomic surveillance of the COVID-19 epidemic in England has cast light how different variants of SARS-CoV-2 spread in the population since autumn 2020...
28 June 2021 - by Anna Wernick 
A controversial paper suggests that Chinese researchers retracted early COVID-19 viral sequences from a US database to obscure their origins...
1 February 2021 - by Dr Eleanor Lynam 
The UK has offered to use its world-leading expertise in genomics to aid countries that lack the resources to identify evolving variants of the SARS-CoV-2 virus...
25 January 2021 - by Christina Burke 
Monitoring of the COVID-19 pandemic has relied heavily on genomic sequencing, but experts warn more needs to be done to control the virus...
19 October 2020 - by Bethany Muller 
$100 million has been invested into the launch of Africa Pathogen Genomics Initiative through the Africa Centres for Disease Control and the African Union Commission...
7 September 2020 - by Dr Barbara Kramarz 
While the world is gradually heading towards a new form of normality, the biomedical research communities continue to work hard and fast in order to improve our understanding of SARS-CoV-2 and our ability to protect humanity from coronavirus disease 2019 (COVID-19)...
to add a Comment.

By posting a comment you agree to abide by the BioNews terms and conditions

Syndicate this story - click here to enquire about using this story.